{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:45:28Z","timestamp":1783565128122,"version":"3.55.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012365","name":"Howard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS073884"],"award-info":[{"award-number":["R01NS073884"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jns.2022.120404","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T03:08:24Z","timestamp":1662088104000},"page":"120404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Why haven't we solved the addiction crisis?"],"prefix":"10.1016","volume":"442","author":[{"given":"Kenneth","family":"Blum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Bowirrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Llanos","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. William","family":"Downs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasis","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debmalya","family":"Barh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Modestino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayotis","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Ceccanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Elman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra D.","family":"Badgaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dennen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashim","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2022.120404_bb0005","author":"SAaMHSA"},{"key":"10.1016\/j.jns.2022.120404_bb0010","author":"Prevention CfDCa"},{"key":"10.1016\/j.jns.2022.120404_bb0015","series-title":"Monitoring the Future National Survey Results on Drug use, 1975\u20132021","volume":"vol. 1","author":"National Institutes of Health NIoDA","year":"2021"},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0020","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11524-022-00610-0","article-title":"Impact of the COVID-19 pandemic on opioid overdose deaths: a spatiotemporal analysis","volume":"99","author":"Ghose","year":"2022","journal-title":"J. Urban Health"},{"issue":"8","key":"10.1016\/j.jns.2022.120404_bb0025","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/add.15957","article-title":"Need for comprehensive and timely data to address the opioid overdose epidemic without a blindfold","volume":"117","author":"Volkow","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.jns.2022.120404_bb0030","author":"Davenport"},{"issue":"5","key":"10.1016\/j.jns.2022.120404_bb0035","first-page":"811","article-title":"Food addiction: a common neurobiological mechanism with drug abuse","volume":"23","author":"Lindgren","year":"2018","journal-title":"Front. Biosci. (Landmark ed.)."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1467-789X.2012.01031.x","article-title":"Obesity and addiction: neurobiological overlaps","volume":"14","author":"Volkow","year":"2013","journal-title":"Obes. Rev.: Off. J. Intern. Assoc. Study Obes."},{"issue":"12","key":"10.1016\/j.jns.2022.120404_bb0045","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2174\/138161211795656855","article-title":"Food addiction and neuroimaging","volume":"17","author":"Zhang","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"10.1016\/j.jns.2022.120404_bb0050","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41593-018-0275-1","article-title":"Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders","volume":"21","author":"Walters","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"121","key":"10.1016\/j.jns.2022.120404_bb0055","article-title":"Dopamine genetics and function in food and substance abuse","volume":"4","author":"Blum","year":"2013","journal-title":"J. Genet. Syndr. Gene. Ther."},{"key":"10.1016\/j.jns.2022.120404_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2017.01.017","article-title":"Genetic studies of alcohol dependence in the context of the addiction cycle","volume":"122","author":"Reilly","year":"2017","journal-title":"Neuropharmacology."},{"issue":"3","key":"10.1016\/j.jns.2022.120404_bb0065","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/ejn.14171","article-title":"Neurogenetic determinants and mechanisms of addiction to nicotine and smoked tobacco","volume":"50","author":"Sharp","year":"2019","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12880","article-title":"Shared genetic risk between eating disorder- and substance-use-related phenotypes: evidence from genome-wide association studies","volume":"26","author":"Munn-Chernoff","year":"2021","journal-title":"Addict. Biol."},{"key":"10.1016\/j.jns.2022.120404_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.conb.2019.05.005","article-title":"Epigenetics and addiction","volume":"59","author":"Hamilton","year":"2019","journal-title":"Curr. Opin. Neurobiol."},{"issue":"7","key":"10.1016\/j.jns.2022.120404_bb0080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040253","article-title":"Epigenetics of drug addiction","volume":"11","author":"Stewart","year":"2021","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"10","key":"10.1016\/j.jns.2022.120404_bb0085","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI60390","article-title":"Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics","volume":"122","author":"Kreek","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jns.2022.120404_bb0090","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/978-1-4939-9554-7_35","article-title":"The role of epigenetics in addiction: clinical overview and recent updates","volume":"2011","author":"Beayno","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biopsych.2019.06.027","article-title":"Epigenetic mechanisms of opioid addiction","volume":"87","author":"Browne","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jns.2022.120404_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neuropharm.2017.02.002","article-title":"Epigenetic basis of the dark side of alcohol addiction","volume":"122","author":"Pandey","year":"2017","journal-title":"Neuropharmacology."},{"issue":"4","key":"10.1016\/j.jns.2022.120404_bb0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1515\/revneuro-2013-0011","article-title":"Does the dopamine hypothesis explain schizophrenia?","volume":"24","author":"Lau","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.jns.2022.120404_bb0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neubiorev.2016.05.033","article-title":"Reward deficiency and anti-reward in pain chronification","volume":"68","author":"Borsook","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41380-019-0406-4","article-title":"Opposite effects of dopamine and serotonin on resting-state networks: review and implications for psychiatric disorders","volume":"25","author":"Conio","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.jns.2022.120404_bb0120","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1007\/s12035-019-1600-8","article-title":"Understanding the scientific basis of post-traumatic stress disorder (PTSD): precision behavioral management overrides stigmatization","volume":"56","author":"Blum","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0125","doi-asserted-by":"crossref","DOI":"10.15761\/JSIN.1000191","article-title":"Our evolved unique pleasure circuit makes humans different from apes: reconsideration of data derived from animal studies","volume":"4","author":"Blum","year":"2018","journal-title":"J. Syst. Integr. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19010552","article-title":"Hypothesizing in the face of the opioid crisis coupling genetic addiction risk severity (GARS) testing with electrotherapeutic nonopioid modalities such as H-wave could attenuate both pain and hedonic addictive behaviors","volume":"19","author":"Gupta","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.jns.2022.120404_bb0135","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/138920102003190422150527","article-title":"Opioid substitution therapy: achieving harm reduction while searching for a prophylactic solution","volume":"20","author":"Blum","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jns.2022.120404_bb0140","doi-asserted-by":"crossref","DOI":"10.2174\/2211556010666210215155509","article-title":"Exploration of epigenetic state Hyperdopaminergia (surfeit) and genetic trait Hypodopaminergia (deficit) during adolescent brain development","volume":"10","author":"Blum","year":"2021","journal-title":"Curr Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jns.2022.120404_bb0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrn3939","article-title":"The dopamine theory of addiction: 40 years of highs and lows","volume":"16","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2022.120404_bb0150","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/ijo.2016.9","article-title":"A meta-analysis of the relationship between brain dopamine receptors and obesity: a matter of changes in behavior rather than food addiction?","volume":"40","author":"Benton","year":"2016","journal-title":"Int. J. Obes. (2005)"},{"issue":"5","key":"10.1016\/j.jns.2022.120404_bb0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1503\/jpn.140204","article-title":"What\u2019s deficient in reward deficiency?","volume":"39","author":"Leyton","year":"2014","journal-title":"J. Psychiatry Neurosci.: JPN."},{"key":"10.1016\/j.jns.2022.120404_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116733","article-title":"Molecular neurological correlates of endorphinergic\/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS)","volume":"411","author":"Blum","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2022.120404_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117137","article-title":"Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): do homo sapiens acquire or have a reward deficiency syndrome?","volume":"418","author":"Gold","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jns.2022.120404_bb0170","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/1096-8628(20001009)96:5<659::AID-AJMG12>3.0.CO;2-G","article-title":"Family-based study of DRD2 alleles in alcohol and drug dependence","volume":"96","author":"Blomqvist","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"5","key":"10.1016\/j.jns.2022.120404_bb0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/alcalc\/agl043","article-title":"The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small","volume":"41","author":"Berggren","year":"2006","journal-title":"Alcohol Alcohol. (Oxford, Oxfordshire)."},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0180","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0924-9338(00)00207-8","article-title":"Reappraisal of the association between the DRD2 gene, alcoholism and addiction","volume":"15","author":"Gorwood","year":"2000","journal-title":"Eur. Psychiatry: J. Assoc. Eur. Psychiatrists."},{"issue":"3","key":"10.1016\/j.jns.2022.120404_bb0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/ddg055","article-title":"Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor","volume":"12","author":"Duan","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.jns.2022.120404_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122040","article-title":"Deciphering the biological mechanisms underlying the genome-wide associations between computerized device use and psychiatric disorders","volume":"8","author":"Wendt","year":"2019","journal-title":"J. Clin. Med."},{"issue":"23","key":"10.1016\/j.jns.2022.120404_bb0195","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/hmg\/ddm240","article-title":"Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples","volume":"16","author":"Yang","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"24","key":"10.1016\/j.jns.2022.120404_bb0200","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1093\/hmg\/ddl426","article-title":"Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations","volume":"15","author":"Gelernter","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0205","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/s41467-019-10254-5","article-title":"Author correction: genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations","volume":"10","author":"Kranzler","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jns.2022.120404_bb0210","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41593-021-00860-2","article-title":"Bi-ancestral depression GWAS in the million veteran program and meta-analysis in >1.2 million individuals highlight new therapeutic directions","volume":"24","author":"Levey","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.jns.2022.120404_bb0215","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00008571-199712000-00006","article-title":"D2 dopamine receptor gene (DRD2) Taq1 a polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele","volume":"7","author":"Thompson","year":"1997","journal-title":"Pharmacogenetics."},{"issue":"7","key":"10.1016\/j.jns.2022.120404_bb0220","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/archpsyc.1991.01810310066012","article-title":"Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism","volume":"48","author":"Noble","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2022.120404_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033308","article-title":"Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin","volume":"7","author":"Shah","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2022.120404_bb0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.physbeh.2013.05.014","article-title":"\u2018Food addiction\u2019 and its association with a dopaminergic multilocus genetic profile","volume":"118","author":"Davis","year":"2013","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40519-021-01136-1","article-title":"Association of the dopamine D2 receptor rs1800497 polymorphism with food addiction, food reinforcement, and eating behavior in Chilean adults","volume":"27","author":"Obreg\u00f3n","year":"2022","journal-title":"Eat. Weight Disord."},{"issue":"8","key":"10.1016\/j.jns.2022.120404_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/nu12082288","article-title":"Underlying susceptibility to eating disorders and drug abuse: genetic and pharmacological aspects of dopamine D4 receptors","volume":"12","author":"Botticelli","year":"2020","journal-title":"Nutrients."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12889-021-10160-w","article-title":"Dopamine D4 receptor gene polymorphism (DRD4 VNTR) moderates real-world behavioural response to the food retail environment in children","volume":"21","author":"Paquet","year":"2021","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0250","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13073-020-0715-x","article-title":"A chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons","volume":"12","author":"Espeso-Gil","year":"2020","journal-title":"Genome Med."},{"issue":"9","key":"10.1016\/j.jns.2022.120404_bb0255","doi-asserted-by":"crossref","first-page":"E467","DOI":"10.1002\/oby.20202","article-title":"Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity","volume":"21","author":"Carpenter","year":"2013","journal-title":"Obesity (Silver Spring, Md)."},{"key":"10.1016\/j.jns.2022.120404_bb0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.appet.2017.01.004","article-title":"Two novel candidate genes identified in adults from the Newfoundland population with addictive tendencies towards food","volume":"115","author":"Pedram","year":"2017","journal-title":"Appetite."},{"key":"10.1016\/j.jns.2022.120404_bb0265","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.appet.2017.10.021","article-title":"Fetal growth interacts with multilocus genetic score reflecting dopamine signaling capacity to predict spontaneous sugar intake in children","volume":"120","author":"Silveira","year":"2018","journal-title":"Appetite."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0270","first-page":"79","article-title":"Genetic determinants of the alcohol dependence syndrome: searching for an endophenotype associated with sweet liking in families with alcohol addiction","volume":"57","author":"Jab\u0142o\u0144ski","year":"2011","journal-title":"Ann. Acad. Med. Stetin."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0275","doi-asserted-by":"crossref","first-page":"89","DOI":"10.12740\/PP\/20931","article-title":"The analysis of the polymorphic variations of the dopamine gen transporter (DAT1) and the serotonin transporter (5-HTTLPR) in patients with alcohol dependence syndrome with inclusion of the phenotypic feature of sweet liking preference","volume":"48","author":"Jasiewicz","year":"2014","journal-title":"Psychiatr. Pol."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0280","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40519-020-00851-5","article-title":"Associations of the ANKK1 and DRD2 gene polymorphisms with overweight, obesity and hedonic hunger among women from the northwest of Iran","volume":"26","author":"Aliasghari","year":"2021","journal-title":"Eat. Weight Disord."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41398-018-0147-1","article-title":"Dopamine D2 -141C Ins\/Del and Taq1A polymorphisms, body mass index, and prediction error brain response","volume":"8","author":"Frank","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5144\/0256-4947.2012.121","article-title":"Association of genetic polymorphisms of glutamate decarboxylase 2 and the dopamine D2 receptor with obesity in Taiwanese subjects","volume":"32","author":"Chen","year":"2012","journal-title":"Ann. Saudi Med."},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0295","first-page":"101","article-title":"Correlations between polymorphisms in genes coding elements of dopaminergic pathways and body mass index in overweight and obese women","volume":"64","author":"Sikora","year":"2013","journal-title":"Endokrynol. Pol."},{"issue":"6","key":"10.1016\/j.jns.2022.120404_bb0300","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/oby.2009.52","article-title":"Dopamine for \u201cwanting\u201d and opioids for \u201cliking\u201d: a comparison of obese adults with and without binge eating","volume":"17","author":"Davis","year":"2009","journal-title":"Obesity (Silver Spring, Md)."},{"issue":"12","key":"10.1016\/j.jns.2022.120404_bb0305","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.3390\/ijerph8124425","article-title":"Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors","volume":"8","author":"Blum","year":"2011","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"7","key":"10.1016\/j.jns.2022.120404_bb0310","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41593-020-0643-5","article-title":"Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits","volume":"23","author":"Zhou","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.jns.2022.120404_bb0315","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/acer.14154","article-title":"Mechanisms of persistent neurobiological changes following adolescent alcohol exposure: NADIA consortium findings","volume":"43","author":"Crews","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.jns.2022.120404_bb0320","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2017.77","article-title":"Largest GWAS of PTSD (N=20070) yields genetic overlap with schizophrenia and sex differences in heritability","volume":"23","author":"Duncan","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.jns.2022.120404_bb0325","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/jamapsychiatry.2020.1206","article-title":"Association of OPRM1 functional coding variant with opioid use disorder: a genome-wide association study","volume":"77","author":"Zhou","year":"2020","journal-title":"JAMA Psychiatry."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0330","doi-asserted-by":"crossref","first-page":"77","DOI":"10.31887\/DCNS.2010.12.1\/jgelernter","article-title":"Genetics of drug dependence","volume":"12","author":"Gelernter","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.jns.2022.120404_bb0335","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1530-0277.2008.00800.x","article-title":"Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence","volume":"32","author":"Yang","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"7","key":"10.1016\/j.jns.2022.120404_bb0340","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2010.06.002","article-title":"Genetic associations of brain structural networks in schizophrenia: a preliminary study","volume":"68","author":"Jagannathan","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2022.120404_bb0345","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00213-006-0469-1","article-title":"C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency","volume":"188","author":"Jacobsen","year":"2006","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jns.2022.120404_bb0350","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2015.02.018","article-title":"Pleasure systems in the brain","volume":"86","author":"Berridge","year":"2015","journal-title":"Neuron."},{"issue":"2\u20133","key":"10.1016\/j.jns.2022.120404_bb0355","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03033808","article-title":"Dopamine and reward: the anhedonia hypothesis 30 years on","volume":"14","author":"Wise","year":"2008","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0360","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2015.11.027","article-title":"Common brain mechanisms of chronic pain and addiction","volume":"89","author":"Elman","year":"2016","journal-title":"Neuron."},{"key":"10.1016\/j.jns.2022.120404_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.06.003","article-title":"Pain and suicidality: insights from reward and addiction neuroscience","volume":"109","author":"Elman","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0370","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41398-018-0292-6","article-title":"Reward and aversion processing in patients with post-traumatic stress disorder: functional neuroimaging with visual and thermal stimuli","volume":"8","author":"Elman","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0375","article-title":"Fifty years in the development of a Glutaminergic-dopaminergic optimization complex (KB220) to balance brain reward circuitry in reward deficiency syndrome: a pictorial","volume":"1","author":"Blum","year":"2016","journal-title":"Aust. Addic. Sci."},{"issue":"4","key":"10.1016\/j.jns.2022.120404_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174774","article-title":"Enhanced functional connectivity and volume between cognitive and reward centers of na\u00efve rodent brain produced by pro-dopaminergic agent KB220Z","volume":"12","author":"Febo","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0385","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/00325481.2015.994879","article-title":"rsfMRI effects of KB220ZTM on neural pathways in reward circuitry of abstinent genotyped heroin addicts","volume":"127","author":"Blum","year":"2015","journal-title":"Postgrad. Med."},{"issue":"3","key":"10.1016\/j.jns.2022.120404_bb0390","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0149-7634(85)90022-3","article-title":"New concepts in cocaine addiction: the dopamine depletion hypothesis","volume":"9","author":"Dackis","year":"1985","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0395","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2190\/GXPA-98AK-4RR4-HD9B","article-title":"Bromocriptine treatment for cocaine abuse: the dopamine depletion hypothesis","volume":"15","author":"Dackis","year":"1985","journal-title":"Int. J. Psychiatry Med."},{"issue":"9","key":"10.1016\/j.jns.2022.120404_bb0400","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jinsphys.2010.03.014","article-title":"Dopamine down-regulates activity of alkaline phosphatase in Drosophila: the role of D2-like receptors","volume":"56","author":"Bogomolova","year":"2010","journal-title":"J. Insect Physiol."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0405","doi-asserted-by":"crossref","first-page":"14","DOI":"10.17756\/jrdsas.2016-023","article-title":"Hypothesizing that, a pro-dopamine regulator (KB220Z) should optimize, but not hyper-activate the activity of trace amine-associated receptor 1 (TAAR-1) and induce anti-craving of psychostimulants in the long-term","volume":"2","author":"Blum","year":"2016","journal-title":"J. Reward Defic. Syndr. Addict. Sci."},{"key":"10.1016\/j.jns.2022.120404_bb0410","series-title":"StatPearls [Internet]","author":"Jordan","year":"2022"},{"key":"10.1016\/j.jns.2022.120404_bb0415","article-title":"Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual","volume":"7","author":"Blum","year":"2020","journal-title":"J. Syst. Integr. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1874473710666171129225914","article-title":"Role of repetitive transcranial magnetic stimulation (rTMS) in treatment of addiction and related disorders: a systematic review","volume":"10","author":"Makani","year":"2017","journal-title":"Curr. Drug Abuse Rev."},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0425","first-page":"01","article-title":"Pro-dopamine regulator (KB220) a fifty year sojourn to combat reward deficiency syndrome (RDS): evidence based bibliography (annotated)","volume":"1","author":"Blum","year":"2018","journal-title":"CPQ Neurol. Psycol."},{"key":"10.1016\/j.jns.2022.120404_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117252","article-title":"Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: digging out of a hypodopaminergic ditch","volume":"420","author":"Blum","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0435","first-page":"445","article-title":"Modification of cocaine self-administration by buspirone (buspar\u00ae): potential involvement of D3 and D4 dopamine receptors","volume":"16","author":"Bergman","year":"2013","journal-title":"Intern. J. Neuropsychopharmacol.\/Off. Sci. J. Colleg. Intern. Neuropsychopharmacol. (CINP)."},{"issue":"9","key":"10.1016\/j.jns.2022.120404_bb0440","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1517\/14712598.2014.920319","article-title":"The future potential for cocaine vaccines","volume":"14","author":"Orson","year":"2014","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"8","key":"10.1016\/j.jns.2022.120404_bb0445","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","article-title":"Stress, dysregulation of drug reward pathways, and the transition to drug dependence","volume":"164","author":"Koob","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2022.120404_bb0450","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2012.07.011","article-title":"Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine \u03b2-hydroxylase","volume":"73","author":"Kosten","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2022.120404_bb0455","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/02698811211069102","article-title":"Development and validation of the reward deficiency syndrome questionnaire (RDSQ-29)","volume":"36","author":"K\u00f3tyuk","year":"2022","journal-title":"J. Psychopharmacol. (Oxford, Engl.)."},{"issue":"5","key":"10.1016\/j.jns.2022.120404_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12050690","article-title":"FOXN3 and GDNF polymorphisms as common genetic factors of substance use and addictive behaviors","volume":"12","author":"Vereczkei","year":"2022","journal-title":"J. Pers. Med."},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0465","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36687","article-title":"Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0470","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2217\/pgs.10.171","article-title":"Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse","volume":"12","author":"Meyer","year":"2011","journal-title":"Pharmacogenomics."},{"issue":"11","key":"10.1016\/j.jns.2022.120404_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19116395","article-title":"Precision behavioral management (PBM) and cognitive control as a potential therapeutic and prophylactic modality for reward deficiency syndrome (RDS): is there enough evidence?","volume":"19","author":"Madigan","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0480","first-page":"1","article-title":"Promoting precision addiction management (PAM) to combat the global opioid crisis","volume":"2","author":"Blum","year":"2018","journal-title":"Biomed. J. Sci. Tech. Res."},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0485","article-title":"Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD)","volume":"6","author":"Blum","year":"2020","journal-title":"J. Syst. Integr. Neurosci."},{"issue":"7","key":"10.1016\/j.jns.2022.120404_bb0490","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1007\/s12035-021-02312-1","article-title":"High genetic addiction risk score (GARS) in chronically prescribed severe chronic opioid Probands attending multi-pain clinics: an open clinical pilot trial","volume":"58","author":"Moran","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.jns.2022.120404_bb0495","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2174\/1389201021666191210112108","article-title":"Hypodopaminergia and \u201cprecision behavioral management\u201d (PBM): it is a generational family affair","volume":"21","author":"Fried","year":"2020","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jns.2022.120404_bb0500","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2147\/PRBM.S292958","article-title":"A review of DNA risk alleles to determine epigenetic repair of mRNA expression to prove therapeutic effectiveness in reward deficiency syndrome (RDS): embracing \u201cprecision behavioral management\u201d","volume":"14","author":"Blum","year":"2021","journal-title":"Psychol. Res. Behav. Manag."},{"issue":"3","key":"10.1016\/j.jns.2022.120404_bb0505","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12035-014-8726-5","article-title":"Genetic addiction risk score (GARS): molecular neurogenetic evidence for predisposition to reward deficiency syndrome (RDS)","volume":"50","author":"Blum","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0510","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/10826084.2017.1400064","article-title":"A systematic, intensive statistical investigation of data from the comprehensive analysis of reported drugs (CARD) for compliance and illicit opioid abstinence in substance addiction treatment with buprenorphine\/naloxone","volume":"53","author":"Blum","year":"2018","journal-title":"Subst. Use Misuse"},{"issue":"9","key":"10.1016\/j.jns.2022.120404_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104275","article-title":"Systematic evaluation of \u201ccompliance\u201d to prescribed treatment medications and \u201cabstinence\u201d from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs","volume":"9","author":"Blum","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jns.2022.120404_bb0520","first-page":"271","article-title":"Buprenorphine treatment for opioid use disorder in community-based settings: outcome related to intensity of services and urine drug test results","volume":"29","author":"Galanter","year":"2020","journal-title":"Am. J. Add.\/Am. Acad. Psychiatrists Alcohol. Add."},{"issue":"5","key":"10.1016\/j.jns.2022.120404_bb0525","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/02791072.2012.737727","article-title":"Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study","volume":"44","author":"Miller","year":"2012","journal-title":"J. Psychoactive Drugs"},{"issue":"6","key":"10.1016\/j.jns.2022.120404_bb0530","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3810\/pgm.2010.11.2236","volume":"122","author":"Miller","year":"2010","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.jns.2022.120404_bb0535","doi-asserted-by":"crossref","DOI":"10.2174\/2211556010666210215153513","article-title":"Epigenetic repair of terrifying lucid dreams by enhanced brain reward functional connectivity and induction of dopaminergic homeostatic signaling","volume":"10","author":"Blum","year":"2021","journal-title":"Curr. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0540","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1556\/2006.6.2017.081","article-title":"Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD","volume":"7","author":"McLaughlin","year":"2018","journal-title":"J. Behav. Addict."},{"key":"10.1016\/j.jns.2022.120404_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112563","article-title":"Administration of a putative pro-dopamine regulator, a neuronutrient, mitigates alcohol intake in alcohol-preferring rats","volume":"385","author":"Solanki","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.jns.2022.120404_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19095480","article-title":"Proposing a \u201cbrain health checkup (BHC)\u201d as a global potential \u201cstandard of care\u201d to overcome reward dysregulation in primary care medicine: coupling genetic risk testing and induction of \u201cdopamine homeostasis\u201d","volume":"19","author":"Braverman","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"7","key":"10.1016\/j.jns.2022.120404_bb0555","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1007\/s12035-017-0758-1","article-title":"The DRD2 Taq1A A1 allele may magnify the risk of Alzheimer\u2019s in aging African-Americans","volume":"55","author":"Blum","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.jns.2022.120404_bb0560","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/1570159X17666191118125702","article-title":"Neuropharmacological and Neurogenetic correlates of opioid use disorder (OUD) as a function of ethnicity: relevance to precision addiction medicine","volume":"18","author":"Abijo","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12020321","article-title":"Reward deficiency syndrome (RDS) surprisingly is evolutionary and found everywhere: is it \u201cBlowin\u2019 in the wind\u201d?","volume":"12","author":"Blum","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jns.2022.120404_bb0570","article-title":"A comparison of medication-assisted treatment options for opioid addiction: a review of the literature","author":"Spayde-Baker","year":"2021","journal-title":"J. Addict. Nurs."},{"issue":"Suppl","key":"10.1016\/j.jns.2022.120404_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2000.10736099","article-title":"Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors","volume":"32","author":"Blum","year":"2000","journal-title":"J. Psychoactive Drugs"},{"issue":"8","key":"10.1016\/j.jns.2022.120404_bb0580","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1249\/MSS.0000000000001627","article-title":"Exercise reduces dopamine D1R and increases D2R in rats: implications for addiction","volume":"50","author":"Robison","year":"2018","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.jns.2022.120404_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2016.02.034","article-title":"Acupuncture for substance use disorders: a systematic review and meta-analysis","volume":"163","author":"Grant","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jns.2022.120404_bb0590","series-title":"Hypothesizing Synergy between Acupuncture\/Auriculotherapy and Natural Activation of Mesolimbic Dopaminergic Pathways: Putative Natural Treatment Modalities for the Reduction of Drug Hunger and Relapse.","first-page":"8","volume":"1","author":"Blum","year":"2011"},{"key":"10.1016\/j.jns.2022.120404_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2021.106832","article-title":"Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: a six-month follow-up study in an outpatient unit","volume":"117","author":"Daigre","year":"2021","journal-title":"Addict. Behav."},{"issue":"9","key":"10.1016\/j.jns.2022.120404_bb0600","first-page":"401","article-title":"Genetics of emotion","volume":"15","author":"Bevilacqua","year":"2011","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.jns.2022.120404_bb0605","author":"(US) SAaMHSA"},{"issue":"8","key":"10.1016\/j.jns.2022.120404_bb0610","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jamapsychiatry.2022.1652","article-title":"Preaddiction-a missing concept for treating substance use disorders","volume":"79","author":"McLellan","year":"2022","journal-title":"JAMA Psychiatry."},{"issue":"9702","key":"10.1016\/j.jns.2022.120404_bb0615","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.jns.2022.120404_bb0620","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pcd.2018.07.003","article-title":"Effects of lifestyle changes on adults with prediabetes: a systematic review and meta-analysis","volume":"12","author":"Glechner","year":"2018","journal-title":"Prim. Care Diabetes."},{"issue":"2","key":"10.1016\/j.jns.2022.120404_bb0625","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0010-440X(91)90008-Z","article-title":"Alcohol and drug dependence among the elderly: epidemiology, diagnosis, and treatment","volume":"32","author":"Miller","year":"1991","journal-title":"Compr. Psychiatry"},{"issue":"10","key":"10.1016\/j.jns.2022.120404_bb0630","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.mayocp.2019.03.029","article-title":"Medication-assisted treatment for opioid-use disorder","volume":"94","author":"Oesterle","year":"2019","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.jns.2022.120404_bb0635","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0740-5472(85)90043-1","article-title":"Pharmacological approaches to cocaine addiction","volume":"2","author":"Dackis","year":"1985","journal-title":"J. Subst. Abus. Treat."},{"issue":"3\u20134","key":"10.1016\/j.jns.2022.120404_bb0640","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1300\/J251v08n03_06","article-title":"Benzodiazepines: reconsidered","volume":"8","author":"Miller","year":"1990","journal-title":"Adv. Alcohol Subst. Abuse."},{"key":"10.1016\/j.jns.2022.120404_bb0645","doi-asserted-by":"crossref","DOI":"10.15761\/JSIN.1000195","article-title":"Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS\u00ae) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)?","volume":"4","author":"Blum","year":"2018","journal-title":"J. Syst. Integr. Neurosci."},{"issue":"9","key":"10.1016\/j.jns.2022.120404_bb0650","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5694\/j.1326-5377.1986.tb113873.x","article-title":"Treatment of the barbiturate abstinence syndrome","volume":"145","author":"Sullivan","year":"1986","journal-title":"Med. J. Aust."},{"issue":"1","key":"10.1016\/j.jns.2022.120404_bb0655","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1570159X13666160512150918","article-title":"Common Neurogenetic diagnosis and Meso-limbic manipulation of Hypodopaminergic function in reward deficiency syndrome (RDS): changing the recovery landscape","volume":"15","author":"Blum","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jns.2022.120404_bb0660","doi-asserted-by":"crossref","DOI":"10.15761\/JSIN.1000245","article-title":"Hypothesizing high negative emotionality as a function of genetic addiction risk severity (GARS) testing in alcohol use disorder (AUD)","volume":"7","author":"Blum","year":"2020","journal-title":"J. Syst. Integr. Neurosci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22002660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22002660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:00:45Z","timestamp":1758384045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22002660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":132,"alternative-id":["S0022510X22002660"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120404","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why haven't we solved the addiction crisis?","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120404"}}